Information technology plays a key role in an ever-widening range of human activities, including surgery. Medical robotics and computer-assisted surgery (MRCAS) are used in a growing number of operating rooms around the world, largely as a result of the growing popularity of minimally invasive surgical (MIS) techniques. MIS utilizes special instruments that can be inserted and manipulated through small incisions (sometimes no more than a few millimeters long) under remote optical or video guidance, greatly reducing patient trauma and recovery times.
The global market for medical robotics and computer-assisted surgical equipment was worth nearly $2.7 billion in 2013. The market is projected to approach $3.3 billion in 2014 and $4.6 billion by 2019 for a compound annual growth rate (CAGR) of 7% between 2014 and 2019, reports BCC Research. The U.S. accounted for more than 71% of the global MRCAS market in 2013, a share that BCC Research expects to increase to 74.7% by 2019. Europe is the second-largest geographical market for MRCAS, with over 22% of the market in 2013, declining to 18.1% in 2019. The Asia-Pacific region is the fastest-growing market, with a 2014 through 2019 CAGR of 13.4%.
Next generation robot assisted surgical devices are perhaps one of the most advanced developments in the field of medical science. Increasing desire of both patients and surgeons for the most efficient and advanced treatment options is encouraging hospitals to adopt these surgical instruments not only to provide value to their patients and doctors but also to reinforce their reputations.
As the technology is largely being integrated into the medical field, the use and demand of robot-assisted surgical systems is increasing both in developing and developed economies. Presence of untapped growth opportunities in emerging countries such as India, Brazil, and China is expected to serve this market as potential growth opportunities in the future. The demand is basically driven by growing awareness about the potential benefits among patients, surgeons and hospitals, favorable demographic trends, increased expenditure on healthcare, and increasing prevalence of chronic diseases.
According to Xie Ming, founder of Smart Robot Technology Group, China has a chance to develop its own brands in medical robots, especially those used in surgery. Currently, the da Vinci surgical robot is grabbing all the media attention in China. A creation of Intuitive Surgical, Inc., USA; the robot completed its first operation at the provincial hospital in Chengdu in the southwestern province of Sichuan on Sept. 9, 2014. It successfully removed a patient’s gallbladder in approximately 30 minutes.
The growing demand for medical robotics in the healthcare industry has increased significantly over the last few years. People are witnessing a whole new phase of healthcare with automation of surgeries because of its unprecedented accuracy, precision and enhanced dexterity for surgeons, and faster recovery period coupled with reduced pain and discomfort for patients. Technological advancements such as expanded applications of robotic systems, robotics combined with imaging platforms, and capsule robot systems are expected to drive the growth of the global medical systems market in the coming years.
It is, however, important to note that the surgical robots do not replace humans but rather enhance their capabilities to operate with superior visualization of the surgical field, motion scaling, and improved control while filtering the tremor inherent in the human wrist. The worldwide market for robotic surgical technologies holds significant promise and is expected to gradually replace traditionally used methods of surgeries.
For our relevant BCC Research report on medical robotics, visit the following link: